Mumbai, India; April 17th, 2023: Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”) today announced that it has been awarded the ESG Champion Award in the ‘Pharmaceutical & Healthcare sector’ category by KPMG at their ESG Conclave and Awards, 2023, held in Mumbai.
The company emerged as a ‘Champion’ across all three pillars of Environmental, Social and Governance through its advanced initiatives. Cipla’s reduction of its scope 1 & 2 GHG emissions, water usage, and waste generation from their operations in FY22 were outstanding facets under its environmental stewardship. Under social and community-building initiatives, Cipla ensured a supply of necessary drugs for non- communicable diseases, as outlined under WHO’s essential medicines. Apart from its diversity & inclusion initiatives, Cipla also fared well given its strong measures on compliance, transparency and setting wide-ranging multi-stakeholder goals.
Driven by its purpose of ‘Caring for Life’, Cipla has always been dedicated towards enriching lives of the communities they work with. This recognition exemplifies the company’s commitment towards environmental, social and governance stewardship. Cipla has been investing in greener technology and processes, creating social impact for communities, and serving markets to promote healthier people and a healthier planet.
Through this event, KPMG, a leading professional services network, aimed to increase the focus on sustainable action through strategic thought towards positive stakeholder impact and collectively establish a narrative for holistic ESG transformation in India. The conclave coincided with the firm’s 30th year of being in the professional services business in India.